4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine

Catalog No. :
ACAQFI012
CAS No. :
205448-32-4
Molecular Formula :
C17H21ClN2O3
Molecular Weight :
336.82

IUPAC Name:4-(3-((4-chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine

4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$116.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine
IUPAC Name4-(3-((4-chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine
Molecular FormulaC17H21ClN2O3
Molecular Weight336.82
SMILESCOC1=C(OCCCN2CCOCC2)C=C3N=CC=C(Cl)C3=C1
InChI KeyNNBAWPGQHJMVCK-UHFFFAOYSA-N
Synonym4-chloro-6-(Methyloxy)-7-{[3-(4-Morpholinyl)propyl]oxy}quinoline;4-chloro-6-Methoxy-7-(3-Morpholin-4-yl-propoxy)-quinoline;4-(3-((4-CHLORO-6-METHOXYQUINOLIN-7-YL)OXY)PROPYL)MORPHOLINE;Quinoline, 4-chloro-6-methoxy-7-[3-(4-morpholinyl)propoxy]-
CAS No.205448-32-4
PubChem CID22265257

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAQFI012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYOKF625 route compound structure diagram
    ACYOKF625205448-31-3 In Stock
  2. Plus
  3. ACEDMW396 route compound structure diagram
    ACEDMW39657616-74-7 In Stock
  4. Then
  5. ACAQFI012 route product structure diagram
    ACAQFI012205448-32-4 In Stock
Inquiry

2. ACAQFI012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQFI012 route product structure diagram
    ACAQFI012205448-32-4 In Stock
Inquiry

Comments (0)